Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
about
Antiepileptic drugs and bone metabolismThe Impact of Anti-Epileptic Drugs on Growth and Bone MetabolismImpact of antiepileptic drugs on bone health: Need for monitoring, treatment, and prevention strategiesAdverse effects of antiepileptic drugs on bone mineral density in children.Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.Prevalence and risk factors for vitamin D insufficiency among children with epilepsy.Association of 25-Hydroxyvitamin D Deficiency in Pediatric Epileptic Patients.Bone mass and turnover in women with epilepsy on antiepileptic drug monotherapy.Will my child grow up and be normal?Antiepileptic drugs and bone metabolism in children: data from 128 patients.Effects of valproic acid on longitudinal bone growth.Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.In Vitro and In Vivo Osteogenic Activity of Largazole.The impact of the use of antiepileptic drugs on the growth of childrenThe Association Between Antiepileptic Drugs and Bone Disease.Osteoporosis Associated with Epilepsy and the Use of Anti-Epileptics-a Review.Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.Antiepileptics and bone health.Endocrine and metabolic changes in epileptic patients receiving valproic acid.Histone Deacetylases in Bone Development and Skeletal Disorders.Induction of endogenous pathways by antiepileptics and clinical implications.Calcium and Vitamin D Supplement Prescribing Practices among Providers Caring for Children with Autism Spectrum Disorders: Are We Addressing Bone Health?Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome.Evidence-based review of bone strength in children and youth with cerebral palsy.Possible methods for the prevention of bone loss in persons with epilepsy.Vitamin D levels in children and adolescents with antiepileptic drug treatmentBone loss associated with use of antiepileptic drugs.Epilepsy and menopause.Drug-vitamin D interactions: a systematic review of the literatureEpilepsy treatment by sacrificing vitamin D.The problem of osteoporosis in epileptic patients taking antiepileptic drugs.Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy.Histone Deacetylases in Cartilage Homeostasis and Osteoarthritis.Bone Mineral Status in Children with Epilepsy: Biochemical and Radiologic Markers.Vitamin D deficiency in children with epilepsy: Do we need to detect and treat it?The effect of the classical and medium chain triglyceride ketogenic diet on vitamin and mineral levels.A survey of vitamin D level in people with learning disability in long-stay hospital wards in Hong Kong.Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation.
P2860
Q21245075-7925886C-20B0-4198-A2DE-725445E7FB62Q26739054-0E50EA02-27FB-4996-BA89-0874253DA357Q28074005-E2D1242E-65C9-4FE6-BC76-EE77DD94F9CCQ33283736-EA979F0C-663C-4E08-A71D-718818C919FFQ33290977-F88D0337-AACC-4706-9D22-0751C4B15D16Q33614697-DF25A8BF-7C35-492D-9DD0-0A73D33A8418Q33860455-F9C20842-C696-48F2-AED5-5D4997FB55F5Q33861621-5F90BB67-6AF5-47AE-A0EE-D60B846518D7Q33915150-5D4035EB-A340-4F40-9D26-7CFCB5C3D23FQ33941418-1B937DEF-B1F0-4F79-8C8A-439A815481CAQ34253275-A793FC92-FA22-45F5-BE22-C75A9E6261D8Q34307137-B09D8517-288D-4745-84FE-5FA4B7F5FB7DQ34810920-33FC4A5F-E2FA-470B-99D7-3C08FB1B71DEQ35030533-0EBBED9A-4FE2-4E8C-81E5-51E0FCF8F0AAQ35071970-788010A0-A91E-497D-9004-29473E39FEEEQ35537866-2D74E17A-F681-40DE-BF34-59E761B375A5Q35924416-32EA917A-2535-472B-9212-8ABA81511EFFQ36007883-24918E62-BA96-4263-ADB8-EFE20A5F378CQ36059549-E5960C0B-7292-4F97-ACCE-3E14C9565C49Q36142002-1B60E56C-D4B7-40B6-BD35-E1F146E016D1Q36146330-759854DF-FA2B-4E4C-BA85-F8E263D943FFQ36263605-FAF16A3E-2637-4237-BCE1-008BA5AB5B4AQ36706428-95C16AAA-E3F7-4C07-82C2-77B6F07ADC01Q37335897-DC6D097E-072C-4787-8D02-D376615A0136Q37423494-912A2E7E-3BA4-43D3-A3AF-A0CF5D9282E5Q37507951-4D31565E-38E4-43AC-92A5-1B663BF1FC8BQ37606686-12C7D825-FA3B-4866-B75B-F7BFC34871BAQ37702229-7B099CDF-1372-4CE1-A715-3B8A0B80B8D0Q37887545-ED5FEAC5-0D42-42C3-B584-B560EEDFE39FQ38073239-514B6743-C503-4214-822C-A01BDBDFB741Q38205010-E5ACD300-2AAA-4446-80D9-042C39782C83Q38211406-6DF6AF7C-5761-4D4C-B258-0C0B57B40BD9Q38310689-20624DB3-C407-4E2D-BD9C-EB7299C10531Q38893201-3F50CB83-446D-4AFE-953E-314B2AE0B991Q41593934-49226752-F054-4869-899D-42860DFA6CC9Q42152585-964D49E1-3EDF-4BBE-9B27-9068D65A9671Q44777919-447B4711-E656-4157-8942-036D62F15252Q44988396-1E6B96D9-0837-4252-BD58-24E71E367D59Q45030244-A7E7B96C-6D31-48E3-AFCE-F7A86096602FQ46606260-2B18356E-8117-461C-BBC7-C01FBF865B77
P2860
Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Long-term valproate and lamotr ...... ass in children with epilepsy.
@ast
Long-term valproate and lamotr ...... ass in children with epilepsy.
@en
Long-term valproate and lamotr ...... ass in children with epilepsy.
@nl
type
label
Long-term valproate and lamotr ...... ass in children with epilepsy.
@ast
Long-term valproate and lamotr ...... ass in children with epilepsy.
@en
Long-term valproate and lamotr ...... ass in children with epilepsy.
@nl
prefLabel
Long-term valproate and lamotr ...... ass in children with epilepsy.
@ast
Long-term valproate and lamotr ...... ass in children with epilepsy.
@en
Long-term valproate and lamotr ...... ass in children with epilepsy.
@nl
P2093
P2860
P1433
P1476
Long-term valproate and lamotr ...... ass in children with epilepsy.
@en
P2093
P2860
P304
P356
10.1046/J.1528-1157.2001.416800.X
P577
2001-09-01T00:00:00Z